Part,  Chapter, Paragraph

  1    I,     2. 10.  1    |       toxicogenomics) or the impact o food on human health (nutrigenomics).
  2   II,     5.  2.  4    |       hypertension prevalence ( 160 o 95 mmHg; 140 o 90 mmHg;
  3   II,     5.  2.  4    |     prevalence ( 160 o 95 mmHg; 140 o 90 mmHg; 160 mmHg).~Table
  4   II,     5.  2.  6    |       Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy
  5   II,     5.  5.  1    |          health policies in the EU.~o Putting Mental Health on
  6   II,     5.  5.  1    |        European Agenda (1998-2000).~o Integrating Mental health promotion
  7   II,     5.  5.  1    |          through~ these programmes.~o Mental health promotion
  8   II,     5.  5.  1    |           health of young children.~o Supporting Children in Substance
  9   II,     5.  5.  1    |            Abuse Families (2002-3).~o Mental health promotion
 10   II,     5.  5.  1    |          interventions for schools.~o Mental health promotion
 11   II,     5.  5.  1    |       working age and older people.~o Implementation of Mental
 12   II,     5.  5.  1    |            prevention and services.~o The establishment of a Set
 13   II,     5.  5.  1    |          health and health systems.~o The European Review of Suicide
 14   II,     5.  5.  1    |             epidemiological trends.~o The Report of the State
 15   II,     5.  5.  1    |           in several Member States.~o Mental Health Information
 16   II,     5.  5.  3    |             Settertobulte W, Samdal O, Barnekow Rasmussen V, eds.
 17   II,     5.  5.  3    |            Graaf R, Ormel J, Gureje O, Shen Y, Huang Y, Zhang
 18   II,     5.  5.  3    |            G, Karlsson H, Bjarnason O, Bengtsson-Tops A, Dybbro
 19   II,     5.  5.  3    |          000 in prevalence studies (ODonogue and Sander, 1997)
 20   II,     5.  5.  3    |     patients. Epilepsia 44:575-581.~ODonogue MF, Sander JW (1997):
 21   II,     5.  5.  3    |       Sillanpaa M, Jalava M, Kaleva O, Shinnar S (1998): Long-term
 22   II,     5.  5.  3    |     Aldenkamp A, Dreifuss F, Renier O, et al) Boca Raton, FL:
 23   II,     5.  5.  3    |         European-level lobbying by:~o determining the general
 24   II,     5.  5.  3    |          not at risk for job loss);~o identifying demographic
 25   II,     5.  5.  3    |          unemployed people with MS;~o identifying factors that
 26   II,     5.  5.  3    |           to stay in the workforce;~o assess the impact of a variety
 27   II,     5.  5.  3    |            7. References~ ~Bajenaru O, Pascu I (2004): Report
 28   II,     5.  5.  3    |        Boiko A, Deomina T, Favorova O, Gusev E, Sudomoina M, Turetskaya
 29   II,     5.  5.  3    |           PA, Fredrikson M, Axelson O, Granérus AK (1999): Nutritional
 30   II,     5.  5.  3    |              Traficante R, Reid WG, OSullivan DJ, Williamson
 31   II,     5.  5.  3    |           Oertel W, Poewe W, Rascol O, Sampaio C (2006): Review
 32   II,     5.  5.  3    |      Neurosci 27(9):561-568.~Riedel O, Klotsche J, Spottke A,
 33   II,     5.  5.  3    |             30(3):250-255~Schöffski O, v.d. Schulenburg J-M.,
 34   II,     5.  5.  3    |        Spottke AE, Reuter M, Machat O, Bornschein B, von Campenhausen
 35   II,     5.  5.  3    |            MD, Atkinson EJ, Cha RH, O’Brien PC (1993): Levodopa
 36   II,     5.  6.  3    |           23% and 19% respectively (ONeill et al, 2001). There
 37   II,     5.  6.  3    |        countries in the EVOS study (ONeill et al, 2001). Vertebral
 38   II,     5.  6.  3    |            of men and 19% of women (ONeill et al, 2001; Sernbo
 39   II,     5.  6.  6    |           Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ, III (
 40   II,     5.  6.  6    |             M, Nieminen P, Koivisto O (1994): More evidence from
 41   II,     5.  6.  6    |       Health and Welfare)~ ~Johnell O, Kanis JA, Oden A, Sernbo
 42   II,     5.  6.  6    |         1323-1332~Kanis JA, Johnell O, Oden A, De Laet C, Jonsson
 43   II,     5.  6.  6    |           251-258~Kanis JA, Johnell O, Oden A, Jonsson B, De Laet
 44   II,     5.  6.  6    |            590~Kanis JA and Johnell O (2005): Requirements for
 45   II,     5.  6.  6    |            Linos A, Worthington JW, O'Fallon WM, Kurland LT (1980):
 46   II,     5.  6.  6    |      Nessiøy I, Bruusgaard D, Rutle O (1995): Musculoskeletal
 47   II,     5.  6.  6    |             Clin Rheumatol 15:27-48~O'Neill TW, Cooper C, Finn
 48   II,     5.  6.  6    |         1020-1030~Sernbo I, Johnell O (1993): Consequences of
 49   II,     5.  7.  7    |             J, McLaughlin JK, Nyren O (2006): Obesity and risk
 50   II,     5.  7.  7    |             9):1824-33.~Stevens PE, O'donoghue DJ, de LS, Van
 51   II,     5.  8.  7    |              Molstad S, Zetterstrom O. (2004): Early detection
 52   II,     5. 10.  7    |    Petrovsky N, Gendel SM, Gigonzac O, Stelman SJ (2003): Allergen
 53   II,     5. 10.  7    |            13: 741-747.~Strannegard O and Strannegard IL (2001):
 54   II,     5. 11.  3    |             45.~CS Jensen, S Lisby, O Baadsgaard, A Vølund, T
 55   II,     5. 11.  3    |             108.~R Silva, F Pere a, O Bord o, E Silva, A Barr ,
 56   II,     8.  2.  1    |           325.~Scheepers M, Kerr M, O’Hara D, Bainbridge D, Cooper
 57   II,     8.  2.  1    |       Haveman, M., Jørgensen, F., & OFarrell, L., (2005). Brief
 58   II,     9.  1.  1    |           S78-87.~ ~Alran S, Sibony O, Oury JF, Luton D, Blot
 59   II,     9.  3.  2    |           S78-87.~ ~Alran S, Sibony O, Oury JF, Luton D, Blot
 60   II,     9.  3.  3    |             N, Guillaume A, Kontula O (2003): Reproductive behaviour
 61   II,     9.  3.  3    |            533-49.~Bozon M, Kontula O (1998): Sexual initiation
 62   II,     9.  3.  3    |             Settertobultr W, Samdal O, Barnekow Rasmussen V (2004)
 63   II,     9.  3.  3    |           Haavio-Mannila E, Kontula O (2001): Seksin trendit meillä
 64   II,     9.  3.  3    |           Haavio-Mannila E, Kontula O (2003) Sexual trends in
 65  III,    10.  1.  3    |              Gendrop SC, Strickland O (1998): Competence and drug
 66  III,    10.  2.  1    |             04_scenihr/docs/scenihr_o_013.pdf~ ~European Network
 67  III,    10.  2.  1    |         Adami H-O, Bofetta P, Nyrén O (2007): Oral use of Swedish
 68  III,    10.  2.  1    |             CD004148.pub3.~ ~Olsson O, Wikström PH (1982): Effects
 69  III,    10.  2.  1    |     children and adults (WHO, 1994; OMullane et al. 2004) Water
 70  III,    10.  2.  1    |        Athanossouli T, Holbrook WP, O'Mullane DM (2006): A European
 71  III,    10.  2.  1    |          Rev 2003; (1): CD002278.~ ~OMullane DM, Ketley CE, Cochran
 72  III,    10.  2.  1(21)|    Kapantais et al, 2004), Ireland (ONeill et al, 2007; Whelton
 73  III,    10.  2.  1(22)|        Antal et al, 2004), Ireland (ONeill et al, 2007; Whelton
 74  III,    10.  2.  1    |    Authority, 2004; Novakova, 2006; ONeill et al, 2007; Padez
 75  III,    10.  2.  1    |             27.3%, 9-12 years old) (ONeill et al, 2007) and in
 76  III,    10.  2.  1    |           osteoporosis include:~ ~ ~o Calcium. Adequate calcium
 77  III,    10.  2.  1    |            Reference Intake (DRI)).~o Vitamin D. Because it is
 78  III,    10.  2.  1    |          per day may be sufficient.~o Physical activity. Bone
 79  III,    10.  2.  1    |             Settertobulte W, Samdal O, Barnekow Rasmussen V, eds (
 80  III,    10.  2.  1    |              do Carmo I, dos Santos O, Camolas J, Vieira J, Carreira
 81  III,    10.  2.  1    |             fbdg_2007.pdf]~ ~Ekholm O, Kjøller M, Davidsen M,
 82  III,    10.  2.  1    |   Metabolism 50:330-338.~ ~Katz DL, OConnell M, Yeh MC, Nawaz
 83  III,    10.  2.  1    |          Nolan G, Sixsmith J, Walsh O, Cooke M (2003): The national
 84  III,    10.  2.  1    |          Republic (in Slovakian).~ ~O'Neill JL, McCarthy SN, Burke
 85  III,    10.  2.  1    |           Stan odzywienia w oparciu o pomiary antropometryczne
 86  III,    10.  2.  4    |          Burke, 2003; Ellsworth and O'Donnell, 2004): in the future
 87  III,    10.  2.  4    |            at: htt ~ ~Ellsworth DL, ODonnell CJ (2004): Emerging
 88  III,    10.  2.  4    |          Zika E, Papatryfon I, Wolf O, Gómez-Barbero M, Stein
 89  III,    10.  3.  1    |        Downloadable from: htt /MENS_O&O_03.PDF~Villeneuve PJ,
 90  III,    10.  3.  1    |      Downloadable from: htt /MENS_O&O_03.PDF~Villeneuve PJ, Morrison
 91  III,    10.  4.  1    |     included:~ ~· Chronic exposure:~o Mortality (PM) – the dominant
 92  III,    10.  4.  1    |           PM) – the dominant effect~o Development of bronchitis (
 93  III,    10.  4.  1    |         exposure (daily variations)~o Mortality (O3 )~o Hospital
 94  III,    10.  4.  1    |       variations)~o Mortality (O3 )~o Hospital admissions~ ~·
 95  III,    10.  4.  1    |            O3); Cardiovascular (PM)~o Days of restricted activity;
 96  III,    10.  4.  1    |              days off work (PM,O3 )~o Days with symptoms (PM,
 97  III,    10.  5.  1    |             Konlaan, B B. Bygren, L O. Johansson, S E. Visiting
 98  III,    10.  5.  1    |          174-8, 2000 Sep.~Hänninen, O, Palonen, J, Tuomisto, JT,
 99  III,    10.  5.  1    |             Yli-Tuomi, T, Seppänen, O, Jantunen, MJ (2005): Reduction
100  III,    10.  5.  1    |        Loftness V, Hakkinen B, Adan O, Nevalainen A (2007): Elements
101  III,    10.  5.  2    |          from rural to urban areas (O`Reilly et al., 2007).~ ~
102  III,    10.  5.  2    |     accessed on January 23, 2008)~ ~O'Reilly G, O'Reilly D, Rosato
103  III,    10.  5.  2    |             23, 2008)~ ~O'Reilly G, O'Reilly D, Rosato M, Connolly
104   IV,    12. 10        |               Safety awareness~High~o An adequate number of Reporting
105   IV,    12. 10        |              are running in Greece.~o Our National Organization
106   IV,    12. 10        |      program of Pharmacovigilance~ ~o Greece participates in a
107   IV,    12. 10        |        settings~Air pollution~ High~o Law 3010/2002 concerning
108   IV,    12. 10        |           Directive 97/11 and 96/61~o Common Ministerial Decision
109   IV,    12. 10        |         destroy the layer of ozone.~o Ministerial Decision 21475/
110   IV,    12. 10        |            for containment of CO2~ ~o The Ministry of Environment,
111   IV,    12. 10        |             and support this phase.~o The last 5-6 years citizens
112   IV,    12. 10        |      discounts on connections fees)~o In Greece, all vehicles
113   IV,    12. 10        |        updated at least every year.~o Also, the Ministry has developed
114   IV,    12. 10        |         protection can be archived.~o Moreover, every day a Report
115   IV,    12. 10        |            the site of the Ministry~o Useful information about
116   IV,    12. 10        |            air protection measures.~o Finally, a campaign concerning “
117   IV,    12. 10        |            and waste disposal~ High~o 01 regarding "Packaging
118   IV,    12. 10        |         particular with the Euro 2.~o The Ministry for the Environment,
119   IV,    12. 10        |        recovery of packaging waste.~o Law 3010/2002 «Updating
120   IV,    12. 10        |         Directives 97/11 and 96/61.~o Common Ministerial Decision
121   IV,    12. 10        |            partly funded by the E.U~o Common Ministerial Decision
122   IV,    12. 10        |     National and Regional Planning”~o Presidential Degree 117/
123   IV,    12. 10        |    equipment” of 27 January 2003.~ ~o The producers of Electric
124   IV,    12. 10        |         chemical contaminants~ High~o Common Ministerial Decision
125   IV,    12. 10        |     Management of Hazardous Waste”,~o Ministerial Decision 13588/
126   IV,    12. 10        |             of 12th December 1991”.~o Presidential Degree 116/
127   IV,    12. 10        |            2939/01 about recycling.~o Especially for the management
128   IV,    12. 10        |          high~ ~ ~Food safety~ high~o Law 2741/1999 concerning
129   IV,    12. 10        |      Hellenic Food Authority (EFET)~o Common Ministerial Decision
130   IV,    12. 10        |             be certified with HACCP~o Common Ministerial Decision
131   IV,    12. 10        |         genetic modified organisms.~o Ministerial Decisions 34258
132   IV,    12. 10        |           the E.U Regulation 93/99.~o Common Ministerial Decision
133   IV,    12. 10        |            Code about road safety~ ~o Law 3542/2007 (in comparison
134   IV,    12. 10        |       violation of the regulations.~o TV spots are used by the
135   IV,    12. 10        |             events and health~ high~o The direction 1299/2003
136   IV,    12. 10        |          determinants~Poverty~ high~o Recently (15/1/2008) the
137   IV,    12. 10        |        estimated limits of poverty.~o Law 2434/1996 established
138   IV,    12. 10        |            000 eligible pensioners.~o The Greek State provides
139   IV,    12. 10        |                 Gender issues~ high~o Law 1329/1983: Modernization
140   IV,    12. 10        |       principle of gender equality.~o Law 1414/1984: Gender equality
141   IV,    12. 10        |           117 and 76/207 of the EU.~o Law 2839/2000: Balanced
142   IV,    12. 10        |            decision-making centers.~o Law 3488/2006: Enforcement
143   IV,    12. 10        |             the working conditions.~o Law 3500/2006: Encounter
144   IV,    12. 10        |    Work-related health issues~ high~o Law 1568/1985Health and
145   IV,    12. 10        |            and Safety of employees”~o Presidential Degree 105/
146   IV,    12. 10        |            Council Directive: 92/58~o Presidential Degree 16/1996 “
147   IV,    12. 10        |         Council Directive 89/654’’.~o Presidential Degrees 88/
148   IV,    12. 10        |        Directives 93/104, 2000/34’’~o Presidential Degrees 17/
149   IV,    12. 10        |       Directives: 89/391 and 91/383~o Presidential Degrees 396/
150   IV,    12. 10        |           655, 89/655 respectively.~o Law 3227/2004 Concerning
151   IV,    12. 10        |   Employment and Social Protection)~o The Greek Ministry of Employment
152   IV,    12. 10        |     different themes, every year.~ ~o Especially concerning work-related
153   IV,    12. 10        |          Objectives of the Program:~o Improving employability
154   IV,    12. 10        |        relation to the labor market~o Developing entrepreneurship
155   IV,    12. 10        |    strengthening the social economy~o Encouraging adaptability
156   IV,    12. 10        | adaptability of firms and employees~o Strengthening the equal
157   IV,    12. 10        |   STRATEGIES AND REPORTS (GREECE)~ ~o The Law 3370 on 11th July
158   IV,    12. 10        |       European Union and the WHO.~ ~o The Ministry of Health and